Pharma News

Experts have designed and synthesized a nanometer-scale DNA "machine" that can make the process of detecting the antibodies that can help with the diagnosis of infectious and auto-immune diseases such as rheumatoid arthritis and HIV much cheaper. The findings were detailed in the journal Angewandte Chemie.

Flu immunisations with four times the strength of standard flu shots significantly reduces the risk hospitalisation of the elderly during the influenza season, new research has found.

Scientists are now better able to predict how quickly the HIV will return after individuals stop treatment, thanks to the discovery of new immune system biomarkers by researchers at the University of New South Wales (UNSW), Australia, and the University of Oxford.

A combination and sequence of antibiotics can effectively hinder the development of antibiotic-resistant bacteria, a study found. Researchers at Moffitt Cancer Centre, Florida, have developed a novel mathematical method, inspired by Darwinian evolution, to use current antibiotics to eliminate or reduce the development of antibiotic-resistant bacteria.

Thirty three percent of a total of 1,252 Middle East Respiratory Syndrome (MERS) coronavirus cases reported over the past four years in Saudi Arabia took place within hospitals, a media report said on Saturday.

Eli Lilly and Company plans to add 30,000 square feet and approximately 50 new jobs to its research and development presence at the Alexandria Center for Life Science in New York, New York.

[adsense:336x280:8701650588]

Researchers have found a way to use diamonds to act as beacons in magnetic resonance imaging (MRI) scans and identify cancerous tumours before they become life-threatening.

A compound that blocks the Ebola virus's ability to replicate has been found to provide full protection to monkeys when treated three days after the deadly infection, researchers have reported.

The US Food and Drug Administration approved Alkermes Inc's Aristada (aripiprazole lauroxil) extended release injection to treat adults with schizophrenia.  Schizophrenia is a chronic, severe and disabling brain disorder affecting about one percent of Americans. Typically, symptoms are first seen in adults younger than 30 years of age. Aristada is administered by a health care professional every four to six weeks using an injection in the arm or buttocks.